- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Yale New Haven Hospital-Smilow Cancer Center New Haven, Connecticut, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Blood Protein Disorders
Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
570 recruiting studies
Blood Protein Disorders trial results
NCT06561347
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Colorado Blood Cancer Institute (CBCI) Denver, Colorado, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT00001244
- Conditions
- Agammaglobulinemia, Blau Syndrome, Blau syndrome, +10 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT05272826
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- NL Health Services St. John's, Newfoundland and Labrador, Canada
- QEII Health Science Centre Halifax, Nova Scotia, Canada
- London Health Sciences Centre London, Ontario, Canada
NCT07479979
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- University of Wisconsin Madison, Wisconsin, United States
Recruiting
Elranatamab in R/R Multiple Myeloma
NCT06138275
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT05652335
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +22 more
- Locations
-
- City of Hope Duarte, California, United States
- City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
- University of California San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
NCT06375044
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Mayo Clinic Arizona Phoenix, Arizona, United States
- Mayo Clinic Florida Jacksonville, Florida, United States
- Dana Farber Cancer institution Boston, Massachusetts, United States
- Mayo Clinic Rochester Rochester, Minnesota, United States
NCT06285318
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Aalborg Sygehus Syd Aalborg, Denmark
- Aarhus Universitetshospital Aarhus N, Denmark
- Rigshospitalet Copenhagen, Denmark
- Odense University Hospital Odense, Denmark
NCT05344833
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- University of Illinois at Chicago Chicago, Illinois, United States
- Huntsman Cancer Institute Salt Lake City, Utah, United States